Intestinal amoebiasis and pediatric inflammatory bowel disease in an endemic region: Three case reports
Abstract
BACKGROUND: Differentiating superadded amoebic colitis (AC) from a disease flare in children with ulcerative colitis (UC) is challenging, particularly in endemic regions, yet remains crucial for guiding appropriate therapy and preventing adverse outcomes.
CASE SUMMARY: We report three children with UC and intestinal amoebiasis; two presenting as disease exacerbation and one with first presentation as acute severe colitis (ASC), highlighting key diagnostic and therapeutic dilemmas. Two children with UC, previously in clinical remission on maintenance therapy, presented with abdominal pain and bloody diarrhea; one had fever of short duration. A provisional diagnosis of disease flare was made in both. The third case presented for the first time as ASC, was treated outside with corticosteroids and referred due to non-response. Stool microscopy identified amoebic trophozoites with haemophagocytosis, consistent with Entamoeba histolytica in all. Initial anti-amoebic therapy with metronidazole resulted in transient clinical improvement; however, each patient subsequently required escalation of immunosuppression for symptom control. Our cases suggest the co-existence of AC over active UC at the same time.
CONCLUSION: Amoebiasis screening in endemic regions is helpful in flare of UC to avoid misdiagnosis and inappropriate escalation of immunosuppressive therapy.
Related
- La gran simuladora: tres casos de enfermedad inflamatoria intestinal asociada a errores innatos de la inmunidad The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects
- Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance
- Pediatric inflammatory bowel disease in New Zealand study: a 10-year update on national incidence and point prevalence in 2025
- Standardized Tool for Prophylaxis (SToP) of venous thromboembolism: An asynchronous curriculum to enhance venous thromboembolism prevention in pediatric inflammatory bowel disease.
- Organ-Specific Clinical Patterns of Pediatric Cystic Echinococcosis: A Multicenter Cohort from an Endemic Region
BibTeX
@article{kumari2026intestinal,
title = {{Intestinal amoebiasis and pediatric inflammatory bowel disease in an endemic region: Three case reports}},
author = {Nitu Kumari and Anshu Srivastava and Moinak Sen Sarma and Ujjal Poddar},
journal = {World Journal of Clinical Pediatrics},
year = {2026},
month = nov,
doi = {10.5409/wjcp.121468},
url = {https://doi.org/10.5409/wjcp.121468},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Intestinal amoebiasis and pediatric inflammatory bowel disease in an endemic region: Three case reports
AU - Nitu Kumari
AU - Anshu Srivastava
AU - Moinak Sen Sarma
AU - Ujjal Poddar
PY - 2026
DA - 2026/11/03
JO - World Journal of Clinical Pediatrics
DO - 10.5409/wjcp.121468
UR - https://doi.org/10.5409/wjcp.121468
AB - BACKGROUND: Differentiating superadded amoebic colitis (AC) from a disease flare in children with ulcerative colitis (UC) is challenging, particularly in endemic regions, yet remains crucial for guiding appropriate therapy and preventing adverse outcomes. CASE SUMMARY: We report three children with UC and intestinal amoebiasis; two presenting as disease exacerbation and one with first presentation as acute severe colitis (ASC), highlighting key diagnostic and therapeutic dilemmas. Two children with UC, previously in clinical remission on maintenance therapy, presented with abdominal pain and bloody diarrhea; one had fever of short duration. A provisional diagnosis of disease flare was made in both. The third case presented for the first time as ASC, was treated outside with corticosteroids and referred due to non-response. Stool microscopy identified amoebic trophozoites with haemophagocytosis, consistent with Entamoeba histolytica in all. Initial anti-amoebic therapy with metronidazole resulted in transient clinical improvement; however, each patient subsequently required escalation of immunosuppression for symptom control. Our cases suggest the co-existence of AC over active UC at the same time. CONCLUSION: Amoebiasis screening in endemic regions is helpful in flare of UC to avoid misdiagnosis and inappropriate escalation of immunosuppressive therapy.
SN - 2219-2808
ER -